Skip to main content

People in the News: Deanna Church, Robert Nussbaum, Robert Green, More

Premium

Personalis has hired Deanna Church to the position of senior director of genomics and content. Church joined Personalis from the National Institutes of Health's National Center for Biotechnology Information, where she was a staff scientist for 12 years. She holds a PhD from the University of California, Irvine and a BA from the University of Virginia.

Personalis has also appointed Robert Nussbaum to its clinical and scientific advisory board. Nussbaum is a professor of medicine and chief of the division of genomic medicine at the University of California, San Francisco.


Bina Technologies, which is developing clinical analysis tools for whole-genome sequencing, has appointed Robert Green, Shashikant Kulkarni, Rong Chen, and Mark Gerstein to its scientific advisory board.

Green is an associate professor of medicine in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. He is also associate director for research at the Partners HealthCare Center for Personalized Genetic Medicine.

Kulkarni is director of cytogenomics and molecular pathology, director of the Clinical Genomics Research Unit, and an associate professor of pediatrics, genetics, and pathology at the Washington University School of Medicine.

Chen is director of clinical genome informatics at the Icahn Institute of Genetics and Multiscale Biology.

Gerstein is the Albert Williams Professor of Biomedical Informatics, Molecular Biophysics & Biochemistry, and Computer Science at Yale University.

In addition, Bina has hired Janet Lankard as vice president of sales and Gianfranco de Feo as vice president of marketing.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.